HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials.

AbstractOBJECTIVE:
Concurrent use of benzodiazepines and psychotherapy for panic disorder is a prevalent but highly controversial practice. Although there are many rationales for that approach, critics contend that benzodiazepines foster drug abuse and dependence and undermine psychosocial treatments in various ways. The authors examine that controversy in the light of recent empirical findings and offer some tentative conclusions and recommendations.
METHOD:
Data from studies combining benzodiazepines and the leading psychosocial treatment for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their application to clinical practice is discussed.
RESULTS:
The strongest support for combined treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patients with agoraphobia and for those whose benzodiazepine treatment is being discontinued. The greatest problem with combined treatment is relapse after drug discontinuance.
CONCLUSIONS:
Combined treatment may be advantageous for some patients, but it must be carefully designed to avoid potential problems. Suggestions for that are given.
AuthorsD A Spiegel, T J Bruce
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 154 Issue 6 Pg. 773-81 (Jun 1997) ISSN: 0002-953X [Print] United States
PMID9167504 (Publication Type: Journal Article, Review)
Chemical References
  • Benzodiazepines
  • Diazepam
Topics
  • Agoraphobia (drug therapy, psychology, therapy)
  • Animals
  • Benzodiazepines (adverse effects, pharmacology, therapeutic use)
  • Clinical Trials as Topic
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Diazepam (therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Fear (drug effects)
  • Humans
  • Panic Disorder (drug therapy, psychology, therapy)
  • Rats
  • Recurrence
  • Substance Withdrawal Syndrome (etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: